IL1A and myalgic encephalomeyelitis/chronic fatigue syndrome: Despite the prominent role of IL-1 in inducing fatigue, an RCT failed to find evidence for the efficacy of anakinra, an IL-1 receptor antagonist, in CFS patients [60].